Current member

Home > Member > Current member
Name 강이중 (연구강사) 
Tel 031-219-5144 
E-mail rkdflwnd@nate.com 

Publication list

1. 3'-Sialyllactose as an inhibitor of p65 phosphorylation ameliorates the progression of experimental rheumatoid arthritis. British Journal of Pharmacology. 2018

2. Jeon J, Kang LJ et al., 3'-Sialyllactose protects against osteoarthritic development by facilitating cartilage homeostasis. J Cell Mol Med. 2017 Aug 7

3. Kang et al., Stimulation of DDX3 expression by ginsenoside Rg3 through the Akt/p53 pathway activates the immune response via TBK1/IKKε/IRF3 signalling. Current Medical Chemistry. 2014

4. Kang et al., Stimulation of TRAF6/TAK1 degradation and inhibition of JNK/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replicationi. The International Journal of Briochemistry & Cell Biology. 2013

5. Kang et al., Antidiabetic effect of propolis: reduction of expression of glucose-6 phosphatase through inhibition of Y279 and Y216 autophosphorylation of GSK-3α/β in HepG2 cells. Phytotherapy Research. 2010 


Patent

1. 3'-시알릴락토오스 또는 이의 유도체를 유효성분으로 함유하는 퇴행성관절염의 예방 또는 치료용 조성물. 대한민국특허 등록: 10-1773066

2. 6'-시알릴락토오스 또는 이의 유도체를 유효성분으로 함유하는 퇴행성관절염의 예방 또는 치료용 조성물. 대한민국특허 등록: 10-1773067










목록